Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been given an average rating of “Moderate Buy” by the eleven research firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eight have given a […]
14 Jan 12:58 · The Markets Daily